| Bioactivity | GYKI-16084 is a new compound that can be isolated from dog and rat urine. GYKI-16084 can be used in the research of benign prostatic hyperplasia[1]. |
| CAS | 185739-21-3 |
| Formula | C16H19N3O3 |
| Molar Mass | 301.34 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. K. Migléczi, et al. Two Stage Solid Phase Extraction with Subsequent HPLC Isolation for Structure Elucidation of Major Metabolites of (+)-(R)-2-{3-(benzo[1,4]dioxan-2-yl-methylamino)-1-propyl}-3(2H)-pyridazinone (GYKI-16084). Chromatographia. 2004, 60, S67–S74. |
GYKI-16084
CAS: 185739-21-3 F: C16H19N3O3 W: 301.34
GYKI-16084 is a new compound that can be isolated from dog and rat urine. GYKI-16084 can be used in the research of beni
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.